Healthcare & Life Sciences

iOrganBio

United Statesiorgan.bio
seed
seed
Stage
1
Investors

About

iOrganBio develops an AI-driven cell manufacturing platform called CellForge that automates and optimizes the production of human cells for therapeutic and research applications.

Explore iOrganBio's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.